Publications by authors named "Ahrens I"

Background: Patients with ST-segment elevation myocardial infarction (STEMI) are often pretreated with unfractionated heparin (UFH) before a primary percutaneous coronary intervention (PPCI). UFH pretreatment is intended to lessen the thrombotic burden, but there have been conflicting study findings on its safety and efficacy. We assessed the risks and benefits of UFH pretreatment with a retrospective analysis of registry data from the STEMI network of a German metropolitan region.

View Article and Find Full Text PDF
Article Synopsis
  • Recent guidelines advocate for quick initiation of lipid-lowering therapy (LLT) in patients with acute coronary syndromes (ACS) to achieve significant reductions in LDL cholesterol levels.
  • A European study involving 286 ACS patients evaluated the effectiveness of two LLT strategies: high-intensity statin monotherapy (mono-HIS) and a combination of high-intensity statins with ezetimibe (combo-HIS).
  • Findings showed that while LDL-c targets were met in under half of the patients, combo-HIS was linked to a significantly greater reduction in LDL-c levels compared to mono-HIS, suggesting its potential for more effective management in post-ACS care.*
View Article and Find Full Text PDF

Chest pain poses a diagnostic challenge in the emergency department and requires a thorough clinical assessment. The traditional distinction between "atypical" and "typical" chest pain carries the risk of not addressing nonischemic clinical pictures. The newly conceived subdivision into cardiac, possibly cardiac, and (probably) noncardiac causes of the presenting symptom complex addresses a much more interdisciplinary approach to a symptom-oriented diagnostic algorithm.

View Article and Find Full Text PDF

Background: Reperfusion therapy is challenging in the elderly. Catheter-directed therapies are an alternative for higher-risk pulmonary embolism (PE) patients if systemic thrombolysis (ST) is contraindicated or has failed. Their safety has not been evaluated in specific vulnerable populations.

View Article and Find Full Text PDF
Article Synopsis
  • - Conventional dual antiplatelet therapy (DAPT) involves the use of aspirin and a potent P2Y inhibitor (prasugrel or ticagrelor) for 12 months in patients with acute coronary syndromes, which lowers ischaemic risk but raises the likelihood of bleeding.
  • - Strategies to minimize bleeding include de-escalating DAPT intensity (switching to a less potent P2Y inhibitor or lower doses) or shortening the duration of therapy, both of which need careful risk assessment for each patient.
  • - The Consensus Statement summarizes existing evidence for these strategies, highlights the importance of assessing ischaemic and bleeding risks, and offers expert guidance to help clinicians customize DAPT approaches for better patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Acute heart failure (AHF) is a complex condition influenced by both sudden triggers and existing heart issues, often linked to valvular heart disease (VHD).
  • Patients with AHF may show varying symptoms, ranging from mild heart failure to severe cases like cardiogenic shock, making it tough to assess their condition accurately.
  • Current treatment guidelines for AHF patients with severe VHD are unclear due to limited evidence from clinical trials, prompting a need for more research on this specific group.
View Article and Find Full Text PDF
Article Synopsis
  • Patients who have experienced acute coronary syndrome (ACS) are at high risk for recurrent cardiovascular events, particularly shortly after the initial event.
  • The relationship between lowering low-density lipoprotein cholesterol (LDL-C) levels and reducing cardiovascular risks post-ACS has led to guidelines advocating for targeted lipid-lowering therapy (LLT), but many patients do not receive adequate treatment.
  • A new approach suggests aggressively starting a combined treatment of high-intensity statins and ezetimibe immediately after ACS, along with mentioning innovative treatments like PCSK9 inhibitors, while also addressing barriers to effective patient care.
View Article and Find Full Text PDF

Objectives: We assessed healthcare resource utilization (HCRU) and costs of cardiovascular (CV) events in patients with a history of atherosclerotic cardiovascular disease (ASCVD) in Germany.

Methods: We conducted a retrospective matched case-control study based on German claims data from 1 January 2012 to 31 December 2017 using the "Institute for Applied Health Research Berlin" (InGef) Research Database. Cases who had a myocardial infarction (MI), stroke and angina pectoris identified by ICD-10-GM codes between 1 January 2014 and 31 December 2016 were matched to event-free controls by an exact matching approach without replacement at a ratio of 1:2.

View Article and Find Full Text PDF

Background: Over the last years, multidisciplinary pulmonary embolism response teams (PERTs) have emerged to encounter the increasing variety and complexity in the management of acute pulmonary embolism (PE). We aimed to systematically investigate the composition and added clinical value of PERTs.

Methods: We searched PubMed, CENTRAL and Web of Science until January 2022 for articles designed to describe the structure and function of PERTs.

View Article and Find Full Text PDF

Aims: Cardiogenic shock (CS) is a life-threatening condition burdened by mortality in up to 50% of cases. Few recommendations exist with intermediate-low level of evidence on CS management and no data on adherence across centres exist. We performed a survey to frame CS management at multinational level.

View Article and Find Full Text PDF

Background: Point-of-care (POC) polymerase chain reaction (PCR) tests have the ability to improve testing efficiency in the Coronavirus disease 2019 (COVID-19) pandemic. However, real-world data on POC tests is scarce.

Objective: To evaluate the efficiency of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) POC test in a clinical setting and examine the prognostic value of cycle threshold (CT) on admission on the length of hospital stay (LOS) in COVID-19 patients.

View Article and Find Full Text PDF